全文获取类型
收费全文 | 515217篇 |
免费 | 33791篇 |
国内免费 | 623篇 |
专业分类
耳鼻咽喉 | 6919篇 |
儿科学 | 16927篇 |
妇产科学 | 13569篇 |
基础医学 | 85130篇 |
口腔科学 | 14521篇 |
临床医学 | 44500篇 |
内科学 | 94068篇 |
皮肤病学 | 12175篇 |
神经病学 | 36250篇 |
特种医学 | 18538篇 |
外国民族医学 | 63篇 |
外科学 | 77416篇 |
综合类 | 8494篇 |
一般理论 | 120篇 |
预防医学 | 39005篇 |
眼科学 | 12204篇 |
药学 | 40577篇 |
中国医学 | 1008篇 |
肿瘤学 | 28147篇 |
出版年
2018年 | 4977篇 |
2015年 | 4580篇 |
2014年 | 6128篇 |
2013年 | 9628篇 |
2012年 | 13029篇 |
2011年 | 14399篇 |
2010年 | 8369篇 |
2009年 | 7841篇 |
2008年 | 13812篇 |
2007年 | 14824篇 |
2006年 | 15045篇 |
2005年 | 14469篇 |
2004年 | 14137篇 |
2003年 | 13457篇 |
2002年 | 13313篇 |
2001年 | 24090篇 |
2000年 | 25088篇 |
1999年 | 20563篇 |
1998年 | 5433篇 |
1997年 | 4707篇 |
1996年 | 5042篇 |
1995年 | 4625篇 |
1994年 | 4321篇 |
1993年 | 4138篇 |
1992年 | 15726篇 |
1991年 | 16311篇 |
1990年 | 16423篇 |
1989年 | 15796篇 |
1988年 | 14577篇 |
1987年 | 14419篇 |
1986年 | 13598篇 |
1985年 | 12976篇 |
1984年 | 9628篇 |
1983年 | 8247篇 |
1982年 | 4560篇 |
1981年 | 4229篇 |
1979年 | 9418篇 |
1978年 | 6855篇 |
1977年 | 5772篇 |
1976年 | 5604篇 |
1975年 | 6397篇 |
1974年 | 7634篇 |
1973年 | 7132篇 |
1972年 | 6960篇 |
1971年 | 6686篇 |
1970年 | 6173篇 |
1969年 | 5889篇 |
1968年 | 5559篇 |
1967年 | 5012篇 |
1966年 | 4450篇 |
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
971.
There is no universally accepted method to determine effective therapy for central sleep apnea (CSA). Continuous positive
airway pressure (CPAP) applied acutely most often does not eliminate apneas and hypopneas. We hypothesized that the application
of two or more therapeutic modalities after the diagnostic phase of polysomnography, a multi-modality titration study (MMTS),
would identify a successful CSA treatment more often than a standard split-night study (SNS) and obviate the need for additional
polysomnograms to determine a successful therapy. We retrospectively analyzed polysomnograms of patients diagnosed with CSA
at our Sleep Disorders Center. We defined a therapy trial that resulted in an apnea–hypopnea index < 10 with at least one
treatment modality as a therapeutic success. One hundred fifteen patients with CSA were studied. Sixty-six patients (57.4%)
underwent a SNS, and 49 patients (42.6%) underwent a MMTS. SNS yielded only 8/66 (12.1%) successes on the first night, whereas
a MMTS yielded 19/49 (38.8%) successes (p = 0.001, two-tailed Fishers exact). Patients who underwent a SNS eventually had similar rate of success as patients studied
with MMTS (60.6 vs 63.3%, NS), but required more testing. Adaptive servo-ventilation was the most successful modality tested,
yielding 36/46 (78.3%) successes. Trials of additional modalities following a failed trial of CPAP often produce a successful
option that may guide therapy in patients with CSA. This approach may lead to establishing the diagnosis and treatment plans
faster, while reducing unnecessary testing. 相似文献
972.
973.
The authors describe 21 cases with resection of the retinal rupture valve with Nd:YAG laser impulse, performed to reduce the vitreoretinal tractions. Resection of the 'dump' rupture valve has been carried out in 10 cases, in the rest 11 the operation has been performed in the presence of a detachment of the retina. Anatomic success (detachment of the valve from the retina) has been achieved in 16 cases. The technique of the surgery is described, as are indications and contraindications to the operation. 相似文献
974.
975.
N-Nitrosodibutylamine (NDBA) and its omega-oxidized metabolites N-nitrosobutyl-4-hydroxybutylamine (4-OH-NDBA) and N-nitrosobutyl-3-carboxypropylamine (BCPN) are potent urinary bladder carcinogens. To study putative organ specific activation of BCPN, its alpha-oxidation by liver and urinary bladder microsomal fractions was investigated in comparison to NDBA and 4-OH-NDBA. Additionally, induction of DNA single strand breaks (SSB) was monitored in hepatocytes and in a human lymphoblastoid cell line (Namalva) in the presence and absence of external metabolic activation, including N-nitroso-t-butyl-n-butylamine as a negative control. BCPN was alpha-hydroxylated and dealkylated at both alkyl chains in small rates (about 1 nmol x mg protein-1 x 60 min-1) by microsomes from rat liver and pig urinary bladder epithelium. NDBA and 4-OH-NDBA were dealkylated at similarly low rates by pig urinary bladder microsomes, in strong contrast to the high debutylation rates observed for rat liver microsomes. Correspondingly, SSB induction by NDBA and 4-OH-NDBA was observed in Namalva cells with NDBA and 4-OH-NDBA in the presence of PB-induced rat liver microsomes but not with urinary bladder microsomes or without external activation. BCPN did not induce DNA-damage in Namalva cells (with or without external activation) or in rat hepatocytes. Significant induction of sister chromatid exchanges (SCEs) and micronuclei, however, was observed in Namalva cells after incubation with NDBA and BCPN. Our data suggest activation of BCPN via alpha-oxidation in the urinary bladder, even though activation rate in-vitro is so low that a positive response is not detectable by several short-term tests. 相似文献
976.
C Crevoisier P Heizmann I Forgo U C Dubach 《European journal of drug metabolism and pharmacokinetics》1989,14(1):23-27
The pharmacokinetics of single- and multiple-dose administration of tenoxicam 20 mg were evaluated in 8 healthy males. Maximum plasma concentration (Cmax) after the first dose was 2.76 +/- 0.48 micrograms/ml (mean +/- s.d.) and the time to reach Cmax (Tmax) was 5.0 +/- 3.0 h. The area under the plasma concentration-time curve (AUC0-infinity) after a single administration of tenoxicam was 242.5 +/- 73.5 micrograms x h/ml. The elimination half-life (t1/2) was 66.3 +/- 15.8 h and the plasma concentration at 24 hours after dosing (Cmin) was 1.84 +/- 0.33 micrograms/ml. Steady-state plasma concentrations of tenoxicam were virtually reached after 10 consecutive daily doses. At steady-state, Cmax averaged 13.63 +/- 3.33 micrograms/ml and Tmax remained 5.0 +/- 3.0 hours. AUC within a dosing interval at steady-state was 262.2 +/- 67.0 micrograms x h/ml, Cminss was 9.67 +/- 3.25 micrograms/ml, and t1/2 averaged 74.2 +/- 13.3 h. The average fluctuation during multiple-dose administration was 26.8 +/- 8.0% and the accumulation ratio was 5.82 +/- 0.60. Steady-state pharmacokinetic parameters predicted from the first-dose data slightly underestimated observed values, but the results supported the assumption of linear pharmacokinetics during multiple-dose tenoxicam administration. 相似文献
977.
978.
979.
There exists a constant need for a dental curing light that works reliably and conveniently in the general practitioner's office and can be used effectively for all the different curing procedures. Due to the need for improved physical properties of resin based composites (RBCs) and less stress at the marginal interface, light curing units (LCUs) experienced significant advances in the past years. The dental industry has focused on reducing the curing time by developing higher intensity curing lights and by altering the resin composition and photo-initiator concentration. As a result the dentist can now choose from a vast variety of curing lights, light intensities and curing methods. This article presents a review of the advances in light curing units and curing techniques, as well as the scientific principles that guided past developments and that will influence future advances. 相似文献
980.